Latest News in the pharma Industry

Market News

Charles River Laboratories acquires Brains On-Line

Charles River Laboratories acquires Brains On-Line

23 Aug 2017

Establishes Charles River as a premier source for CNS contract research services.

Read more 
Bavarian Nordic closes transaction with Janssen Pharmaceuticals

Bavarian Nordic closes transaction with Janssen Pharmaceuticals

22 Aug 2017

Collaboration grants Janssen the exclusive rights to Bavarian Nordic’s MVA-BN technology for two additional programs, targeting vaccines against hepatitis B virus and the human immunodeficiency virus.

Read more 
Amgen and Humana partner for improved health outcomes and efficiency

Amgen and Humana partner for improved health outcomes and efficiency

22 Aug 2017

Partnership to target multiple serious diseases using real world data studies.

Read more 
Spray drying specialist to invest €19 million in GMP facility expansion

Spray drying specialist to invest €19 million in GMP facility expansion

22 Aug 2017

Investment is in response to increased market for spray drying and capsule filling for dry powder inhalers.

Read more 
Oak Therapeutics completes critical milestone in Phase I to develop oral dissolvable strip for TB

Oak Therapeutics completes critical milestone in Phase I to develop oral dissolvable strip for TB

22 Aug 2017

Comapny has created a novel formulation to produce a product prototype containing 300 mg of Isoniazid, that is both rapidly dissolving and mucoadhesive.

Read more 
Oxford Genetics secures £7.5 million investment

Oxford Genetics secures £7.5 million investment

21 Aug 2017

Investment will fund a new office in Boston, US, an extension of its UK facility at the Oxford Science Park, and R&D capabilities to increase its intellectual property portfolio.

Read more 
Champions Oncology collaborates with AstraZeneca to develop unique cohorts of PDX models

Champions Oncology collaborates with AstraZeneca to develop unique cohorts of PDX models

21 Aug 2017

Models will be used in AstraZeneca's oncology R&D programs in breast and lung cancer.

Read more 
RedHill Biopharma announces US commercialization agreement for FDA-approved GI product

RedHill Biopharma announces US commercialization agreement for FDA-approved GI product

21 Aug 2017

Esomeprazole Strontium DR capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor, indicated for adults for the treatment of gastroesophageal reflux disease and other gastrointestinal conditions.

Read more 
Mylan finalizes settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector

Mylan finalizes settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector

17 Aug 2017

Mylan will reclassify EpiPen Auto-Injector for purposes of the Medicaid Drug Rebate Program and pay the rebate applicable to innovator products effective as of 1 April 2017.

Read more 
Pfizer to adopt Orion cloud platform for computational chemistry

Pfizer to adopt Orion cloud platform for computational chemistry

17 Aug 2017

Orion's workflow tools will help Pfizer's efforts to deliver potential breakthrough therapies for patients.

Read more 
Hikma announces new licensing agreement with Takeda for products in the MENA

Hikma announces new licensing agreement with Takeda for products in the MENA

17 Aug 2017

Hikma granted the exclusive rights to manufacture and commercialise three of Takeda’s leading primary care product families.

Read more 
Evotec completes acquisition of Aptuit

Evotec completes acquisition of Aptuit

16 Aug 2017

Employees and capabilities will be integrated into Evotec's global drug discovery group to maximise commercial synergies.

Read more